Back to BARCLAYS PLC BARCLAYS PLC

ADAPYADAPY
28 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs

BARCLAYS PLC previously held 0 shares of ADAPY (ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$2,000

Total Shares Change

-271

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$0.02
0
2025-Q4
Decreased
2,532
-0.1%
$660.0%$0.03
0
2025-Q3
Unchanged
2,534
0.0%
$3300.0%$0.14
0
2025-Q2
Decreased
2,534
-94.9%
$6080.0%$0.25
0
2025-Q1
Increased
50,068
+0.0%
$9,8630.0%$0.21
12
2024-Q4
Unchanged
50,061
0.0%
$26,9680.0%$0.55
0
2024-Q3
Unchanged
50,061
0.0%
$47,5780.0%$0.98
0
2024-Q2
Unchanged
50,061
0.0%
$48,8040.0%$0.98
0
2024-Q1
Unchanged
50,061
0.0%
$79,0960.0%$1.58
0
2023-Q4
Unchanged
50,061
0.0%
$39,6980.0%$0.79
0
2023-Q3
Unchanged
50,061
0.0%
$39,0480.0%$0.78
0
2023-Q2
New
50,061
-
$46,3060.0%$0.94
31
2022-Q4
Exited
0
-100.0%
$00.0%$1.46
0
2022-Q3
Increased
340,068
+34.6%
$366,0000.0%$1.06
31
2022-Q2
New
252,682
-
$430,0000.0%$1.71
33
2021-Q4
Exited
0
-100.0%
$00.0%$3.87
0
2021-Q3
Decreased
11
-77.5%
$00.0%$5.20
0
2021-Q2
Decreased
49
-99.4%
$00.0%$4.39
0
2021-Q1
Increased
8,189
+2.5%
$43,0000.0%$5.05
14
2020-Q4
Increased
7,988
+8.0%
$43,0000.0%$5.41
15
2020-Q3
Unchanged
7,400
0.0%
$59,0000.0%$7.66
0
2020-Q2
Unchanged
7,400
0.0%
$74,0000.0%$9.29
0
2020-Q1
Increased
7,400
+1306.8%
$20,0000.0%$2.75
21
2019-Q4
Decreased
526
-68.0%
$1,0000.0%$1.16
0
2019-Q3
New
1,643
-
$2,0000.0%$1.47
17
2019-Q2
Exited
0
-100.0%
$00.0%$4.02
0
2019-Q1
Increased
871
+221.4%
$4,0000.0%$4.30
16
2018-Q4
New
271
-
$2,0000.0%$5.15
17

Other major holders of ADAPY: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used